Takaoka M - Search Results

1

Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.

Takaoka M, Kobayashi Y, Yuba M, Ohkita M, Matsumura Y. Takaoka M, et al. Eur J Pharmacol. 2001 Jul 20;424(2):121-9. doi: 10.1016/s0014-2999(01)01120-7. Eur J Pharmacol. 2001. PMID: 11476758

2

Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1.

Matsumura Y, Hisaki K, Takaoka M, Morimoto S. Matsumura Y, et al. Among authors: takaoka m. Eur J Pharmacol. 1990 Aug 21;185(1):103-6. doi: 10.1016/0014-2999(90)90216-s. Eur J Pharmacol. 1990. PMID: 2226629

3

Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.

Fujita K, Matsumura Y, Kita S, Miyazaki Y, Hisaki K, Takaoka M, Morimoto S. Fujita K, et al. Among authors: takaoka m. Br J Pharmacol. 1995 Mar;114(5):925-30. doi: 10.1111/j.1476-5381.1995.tb13292.x. Br J Pharmacol. 1995. PMID: 7780646 Free PMC article.

4

Big endothelin-3-induced hypertension and its inhibition by phosphoramidon in anaesthetized rats.

Matsumura Y, Fujita K, Takaoka M, Morimoto S. Matsumura Y, et al. Among authors: takaoka m. Eur J Pharmacol. 1993 Jan 5;230(1):89-93. doi: 10.1016/0014-2999(93)90414-d. Eur J Pharmacol. 1993. PMID: 8094056

5

Role of endothelin-1 in hypertension induced by long-term inhibition of nitric oxide synthase.

Fujita K, Matsumura Y, Miyazaki Y, Takaoka M, Morimoto S. Fujita K, et al. Among authors: takaoka m. Eur J Pharmacol. 1995 Jul 14;280(3):311-6. doi: 10.1016/0014-2999(95)00216-8. Eur J Pharmacol. 1995. PMID: 8566099

6

Involvement of endothelin-1 in deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy.

Matsumura Y, Fujita K, Miyazaki Y, Takaoka M, Morimoto S. Matsumura Y, et al. Among authors: takaoka m. J Cardiovasc Pharmacol. 1995;26 Suppl 3:S456-8. J Cardiovasc Pharmacol. 1995. PMID: 8587444

7

Effects of the endothelin ETA-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.

Fujita K, Matsumura Y, Miyazaki Y, Takaoka M, Morimoto S. Fujita K, et al. Among authors: takaoka m. Jpn J Pharmacol. 1996 Apr;70(4):313-9. doi: 10.1254/jjp.70.313. Jpn J Pharmacol. 1996. PMID: 8774759 Free article.

8

A proteasome inhibitor lessens the increased aortic endothelin-1 content in deoxycorticosterone acetate-salt hypertensive rats.

Okamoto H, Takaoka M, Ohkita M, Itoh M, Nishioka M, Matsumura Y. Okamoto H, et al. Among authors: takaoka m. Eur J Pharmacol. 1998 May 29;350(1):R11-2. doi: 10.1016/s0014-2999(98)00327-6. Eur J Pharmacol. 1998. PMID: 9683028

9

Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.

Matsumura Y, Hashimoto N, Taira S, Kuro T, Kitano R, Ohkita M, Opgenorth TJ, Takaoka M. Matsumura Y, et al. Among authors: takaoka m. Hypertension. 1999 Feb;33(2):759-65. doi: 10.1161/01.hyp.33.2.759. Hypertension. 1999. PMID: 10024341

10

Protective effect of KB-R7943, a novel Na+/Ca2+ exchange inhibitor, on ischemic acute renal failure in rats.

Kuro T, Kobayashi Y, Takaoka M, Matsumura Y. Kuro T, et al. Among authors: takaoka m. Jpn J Pharmacol. 1999 Oct;81(2):247-51. doi: 10.1254/jjp.81.247. Jpn J Pharmacol. 1999. PMID: 10591486 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

701 results

Search Page

Filters